Sinovac gets funding for bird flu vaccine
Sinovac gets funding for flu vaccine

The Associated Press/NEW YORK


Sinovac gets funding for bird flu vaccine

Sinovac gets funding for flu vaccine


DEC. 9 11:33 A.M. ET Beijing-based vaccine developer Sinovac Biotech Ltd. said Friday it received 7 million yuan ($867,000) from China's Ministry of Science and Technology for preclinical trials of its proprietary pandemic flu vaccine, Panflu.

Sinovac said it has received more than $1 million from the Chinese government since April 2004 to develop the bird flu vaccine. The company said the vaccine includes aluminum to boost immune response, which allows for smaller doses -- making it possible to produce more doses quickly and respond to a possible bird flu pandemic.


Biotech News

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech